- 5 Downloads
The word sarcopenia originates from the Greek words sarx (muscle) and -penia (loss). Sarcopenia is a progressive and generalized skeletal muscle disorder that is associated with increased likelihood of adverse outcomes including falls, fractures, physical disability, and mortality.
Sarcopenia increases risk of falls and fractures, impairs ability to perform activities of daily living, leads to mobility disorders and loss of independence, impairs quality of life, and increases need for long-term care placement and death. It increases risk for hospitalization and the cost. It is observed more prevalent by aging, but many other factors contribute and increase risk of developing sarcopenia involving systemic diseases especially organ failures, inflammatory conditions, physical inactivity, nutritional deficiencies, and unhealthy food choices. Hence, sarcopenia may be associated with many prevalent diseases such as cardiac/respiratory/renal diseases, malignancies, and...
- Bahat G, Kilic C, Ilhan B et al (2019) Association of different bioimpedanciometry estimations of muscle mass with functional measures. Geriatr Gerontol Int (in press)Google Scholar
- Cawthon PM, Travison TG, Manini TM et al (2019) Sarcopenia definition and outcomes consortium conference participants. Establishing the link between lean mass and grip strength cut-points with mobility disability and other health outcomes: proceedings of the sarcopenia definition and outcomes consortium conference. J Gerontol A Biol Sci Med Sci 14:glz081. https://doi.org/10.1093/gerona/glz081CrossRefGoogle Scholar
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423. https://doi.org/10.1093/ageing/afq034.CrossRefGoogle Scholar
- Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Writing Group for the European Working Group on sarcopenia in older people 2 (EWGSOP2), and the extended group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169CrossRefGoogle Scholar
- De Spiegeleer A, Beckwée D, Bautmans I et al (2018) Sarcopenia guidelines development group of the Belgian Society of Gerontology and Geriatrics (BSGG). Pharmacological interventions to improve muscle mass, muscle strength and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Drugs Aging 35(8):719–734. https://doi.org/10.1007/s40266-018-0566-y.CrossRefGoogle Scholar
- Kim MJ, Morley JE (2005) The hormonal fountains of youth: myth or reality. J Endocrinol Investig 28(11 Suppl Proceedings):5–14Google Scholar
- Liu CJ, Latham NK (2009) Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev (3):CD002759. https://doi.org/10.1002/14651858.CD002759
- McGregor RA, Cameron-Smith D, Poppitt SD (2014) It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life. Longev Healthspan 3:9Google Scholar
- Yamada Y, Nishizawa M, Uchiyama T et al (2017) Developing and validating an age-independent equation using multi-frequency bioelectrical impedance analysis for estimation of appendicular skeletal muscle mass and establishing a cutoff for sarcopenia. Int J Environ Res Public Health 14. https://doi.org/10.3390/ijerph14070809.CrossRefGoogle Scholar